FDA Approves Dupixent for COPD
The FDA has approved Dupixent for adults with inadequately controlled COPD and an eosinophilic phenotype.
Tag: Regeneron
All
Latest
All
Latest
FDA Expands Authorized Use of Regen-Cov as Preventative Treatment
The FDA expanded authorization of Regen-Cov to include post-exposure prophylaxis in people at high risk for progression to severe COVID-19, who are not fully vaccinated or are not expected to mount an adequate response to vaccination.
